Navigation Links
Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent)
Date:7/20/2013

Albany, NY (PRWEB) July 21, 2013

The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to grow despite continuing product recalls and safety controversies, particularly in the Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers segment. Product innovation, together with demographic structure of the world population, will play a pivotal role in the future growth of the market. Additionally, developing healthcare sector and advanced infrastructure along with infusion of new professional skills and expertise in emerging economies continue to propel long-term growth opportunities for manufacturers operating in the market.

To Read The Complete Report with TOC: http://www.marketresearchreports.biz/analysis-details/global-cardiac-bio-implant-devices-implantable-cardioverter-defibrillators-implantable-cardiac-pacemakers-heart-valve-coronary-stent-peripheral-stent-ventricular-assist-device-market-forecast-clinical-trials-manda

Renub Research study titled “Global Cardiac Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A” provides a comprehensive assessment of the fast-evolving, high-growth global cardiac implant market. This 284 page report with 258 Figures and 24 Tables studies the Global Cardiac Implant Device Market. This report contains 24 chapters and has been bifurcate into 10 segments.

i) Worldwide Cardiac Implants Device Analysis (Chapter 2)
ii) Implantable Cardioverter Defibrillators (ICD) (Chapter 3 to 5)
iii) Implantable Cardiac Pacemakers (ICP) (Chapter 6 to 8)
iv) Heart Valve (Chapter 9 to 11)
v) Coronary Stent (Chapter 12 to 15)
vi) Perpheral Stent (Chapter 16 to 17)
vii) Ventricular Assist Device (Chapter 18 to 20)
viii) Cardiac Implants Devices Clinical Trial Statement (Chapter 21)
ix) Merger & Acquisitions (Chapter 22)
x) Growth Drivers & Challenges (Chapter 22 to 24)

Browse All The Report Of This Publisher Visit: http://www.marketresearchreports.biz/publisher/31

All the above segments have been further sub divided into

a) Market & Forecast (2008 - 2017)
b) Sales Unit & Forecast (By Volume) (2008 - 2017)
c) Market Share & Forecast (2008 - 2017)
d) Companies Market Share & Forecast(2008 - 2017)
e) Companies Revenue & Forecast (2008 - 2017)
f) Clinical Trial Statement
g) Merger & Acquisition
h) Growth Driver & Challenges

The Following 24 Chapters Contains

  •     First chapter is Executive Summary.
  •     Second chapter contains worldwide cardiac implants device market, market share & forecast (2010 – 2017).
  •     Third to Fifth chapter contains implantable cardioverter defibrillators (ICD) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008 – 2017).
  •     Sixth to Eighth chapter contains implantable cardiac pacemakers (ICP) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008 – 2017).
  •     Ninth to Eleventh chapter contains heart valve (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2009-2017).
  •     Twelfth to Fifteenth chapter contains coronary stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008-2017).
  •     Sixteenth to Seventeenth chapter contains peripheral stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2010-2017).
  •     Eighteenth to nineteenth chapter contains ventricular assist device (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2010-2017).
  •     Twentieth to Twenty Three chapters contains clinical trial statement, merger & acquisition, growth driver & challenges.

For Market Research Reports Visit – http://mresearchreports.blogspot.com/

Table of Contents

1. Executive Summary

2. Worldwide Cardiac Implants Device Analysis (2010 – 2017)
2.1 Worldwide – Cardiac Implants Device Market & Forecast
2.2 Worldwide – Cardiac Implants Device Market Share & Forecast

3. Implantable Cardioverter Defibrillators (ICD) Analysis (2008 – 2017)
3.1 Worldwide – ICD Market & Forecast
3.2 Worldwide – ICD Sales Unit & Forecast (By Volume)
3.3 USA vs. Rest of World – ICD Market Share & Forecast
3.4 Companies (Boston Scientific, St Jude Medical, Medtronic & Others) – ICD Market Share & Forecast

4. Implantable Cardioverter Defibrillators (ICD) Market, Volume & Forecast – USA & ROW (2008 – 2017)
4.1 United States – ICD Market & Forecast
4.2 United States – ICD Sales Unit & Forecast (By Volume)
4.3 Rest of the World (ROW) – ICD Market & Forecast
4.4 Rest of the World (ROW) – ICD Sales Unit & Forecast (By Volume)

To Buy a Copy Of This Report: http://www.marketresearchreports.biz/analysis/168251

5. Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast – Companies Analysis (2008 – 2017)
5.1 Boston Scientific Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
5.1.1 Worldwide – Boston Scientific ICD Revenue & Forecast
5.1.2 United States – Boston Scientific ICD Revenue & Forecast
5.1.3 Rest of the World – Boston Scientific ICD Revenue & Forecast
5.2 St Jude Medical Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
5.2.1 Worldwide – St Jude Medical ICD Revenue & Forecast
5.2.2 United States – St Jude Medical ICD Revenue & Forecast
5.2.3 Rest of the World – St Jude Medical ICD Revenue & Forecast
5.3 Medtronic Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
5.3.1 Worldwide – Medtronic ICD Revenue & Forecast
5.3.2 United States – Medtronic ICD Revenue & Forecast
5.3.3 Rest of the World – Medtronic ICD Revenue & Forecast
5.4 Other Companies Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
5.4.1 Worldwide – Other Companies ICD Revenue & Forecast
5.4.2 United States – Other Companies ICD Revenue & Forecast
5.4.3 Rest of the World – Other Companies ICD Revenue & Forecast

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz
Website: http://www.marketresearchreports.biz/
Blog: http://mrrbizmintel.blogspot.com/
Blog: http://marketsbuzz.wordpress.com/

Read the full story at http://www.prweb.com/releases/2013/Cardiac-Bio-Implant/prweb10945889.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Canada should play a role in addressing the global cancer epidemic
3. Global cardiology leaders meet in Dubai
4. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
5. International breast health global summit will focus on supportive care and quality of life
6. Scientists rewrite rulebook on breast cancer in landmark global study
7. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
10. New study identifies how information technology is used to solve global health challenges
11. New global report says US lags behind 130 other nations in preterm birth rate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... Marathon ... all over the country. , Outdoor running increases exposure to ultraviolet radiation, a ... increased risk of melanoma, and only half may be adequately protecting themselves with ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... San Diego ... ) health care reform plan, has announced his candidacy for the 52nd Congressional District ... and shared in America’s Promise. Coming to this country at age eleven after suffering ...
(Date:8/20/2017)... ... ... State Farm Neighborhood Assist® has named The Southern Maryland Team Anti-Bullying Program ... initiative wins, Gals Lead – Dream Queen Foundation’s signature teen girl program to help ... Calvert and Charles Counties. The program could potentially impact nearly 17,500 female students (49.4 ...
(Date:8/19/2017)... MD (PRWEB) , ... August 18, 2017 , ... ... and Drug Administration Reauthorization Act of 2017, legislation that provides for greater public ... mild to moderate hearing loss to access OTC hearing aids without being seen ...
(Date:8/19/2017)... ... August 19, 2017 , ... Parker at Stonegate, an assisted ... passionate employees, caregivers, volunteers, thought leaders, researchers, educators and partners leading the way ... time to refresh the carpeting with the goal of maintaining the same precise ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... DUBLIN, Aug. 8, 2017   ... $3.12 diluted (GAAP) loss per share from continuing operations ... Products revenues increased 16 percent to $110 million ... increased 27 percent to $161 million ... (EPS) from continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology: